BIOMAT Database Logo BIOMAT Database Logo

Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients. 2008

Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Dipartimento di Scienze Mediche e Chirurgiche, Cattedra di Malattie del Metabolismo, Università di Padova, Padova, Italy. annunziata.lapolla@unipd.it

ApoA-I, which constitutes 70% of the apolipoprotein content of high-density lipoproteins, acts as an acceptor for the transfer of phospholipids and free cholesterol from peripheral tissues and transports cholesterol in the liver and other tissue for excretion and steroidogenesis. In order to verify its possible structural alteration in pathological states, plasma samples from healthy, diabetic, and nephropathic subjects have been analyzed by two-dimensional gel electrophoresis. By this approach, clear differences among the three classes of subjects become evident and, in the case of diabetic and nephropathic patients, intense spots are present. The matrix-assisted laser desorption/ionization mass spectrometry analysis of their digestion products shows that an overexpression of unglycated and glycated ApoA-I is present in both pathological states, reasonably affecting the efficiency in cholesterol transport.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Properties of in vitro nonenzymatically glycated plasma fibrinogens.
August 1987, Experimental and clinical endocrinology,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
August 1995, Kidney international,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes.
May 2008, Journal of proteome research,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Composition of plasma ApoA-I-containing lipoprotein particles in children and adults.
March 1991, Pediatric research,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
The oxidative modification of low density lipoprotein by nonenzymatically glycated peptide-Fe complex.
November 1991, Biochimica et biophysica acta,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
February 1996, Journal of the American Society of Nephrology : JASN,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Radioimmunoassay for nonenzymatically glycated protein in human serum.
August 1986, Clinica chimica acta; international journal of clinical chemistry,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles.
January 1991, Progress in lipid research,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Genetic studies of an apoA-I lipoprotein variant.
January 1983, Human genetics,
Annunziata Lapolla, and Maura Brioschi, and Cristina Banfi, and Elena Tremoli, and Chiara Cosma, and Luciana Bonfante, and Simone Cristoni, and Roberta Seraglia, and Pietro Traldi
Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients.
April 1997, Clinical biochemistry,
Copied contents to your clipboard!